BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9198842)

  • 1. [New wave of chemotherapeutic agents: update in pulmonary oncology].
    Sculier JP
    Rev Mal Respir; 1997 Apr; 14(2):154-6. PubMed ID: 9198842
    [No Abstract]   [Full Text] [Related]  

  • 2. New chemotherapeutic agents for non-small cell lung cancer.
    Miller VA; Rigas JR; Grant SC; Pisters KM; Kris MG
    Chest; 1995 Jun; 107(6 Suppl):306S-311S. PubMed ID: 7781411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review.
    Clegg A; Scott DA; Hewitson P; Sidhu M; Waugh N
    Thorax; 2002 Jan; 57(1):20-8. PubMed ID: 11809985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promising new agents in the treatment of non-small cell lung cancer.
    Edelman MJ; Gandara DR
    Cancer Chemother Pharmacol; 1996; 37(5):385-93. PubMed ID: 8599859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for non-platinum chemotherapy in advanced NSCLC.
    Murren JR
    Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):29-34. PubMed ID: 11497229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New drug for therapy of non-small cell lung cancer.
    Klastersky J
    Lung Cancer; 1994 Nov; 11 Suppl 3():S139-49. PubMed ID: 7704506
    [No Abstract]   [Full Text] [Related]  

  • 7. Second-line chemotherapy for recurrent non-small cell lung cancer: do new agents make a difference?
    Ferrigno D; Buccheri G
    Lung Cancer; 2000 Aug; 29(2):91-104. PubMed ID: 10963840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New promising anticancer drugs for lung cancer].
    Ariyoshi Y; Sugiura T
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2578-84. PubMed ID: 7979416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New cytostatics in the therapy of non-small cell bronchial carcinoma].
    Serke M; Schönfeld N; Loddenkemper R
    Pneumologie; 1998 Jun; 52(6):333-7. PubMed ID: 9715648
    [No Abstract]   [Full Text] [Related]  

  • 10. New drugs in non-small cell lung cancer. An overview.
    Giaccone G
    Lung Cancer; 1995 Apr; 12 Suppl 1():S155-62. PubMed ID: 7551924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosensitization with chemotherapeutic agents.
    Caffo O
    Lung Cancer; 2001 Dec; 34 Suppl 4():S81-90. PubMed ID: 11742709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New drugs in gastrointestinal oncology. Current status and future directions].
    Conroy T; Paillot B; Adenis A
    Gastroenterol Clin Biol; 1999 Nov; 23(11):1145-65. PubMed ID: 10651534
    [No Abstract]   [Full Text] [Related]  

  • 14. New agents in the treatment of small cell lung cancer.
    Ghaemmaghami M; Jett JR
    Chest; 1998 Jan; 113(1 Suppl):86S-91S. PubMed ID: 9438696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New therapeutic approaches in non-small-cell lung carcinoma (NSCLC), stages IV].
    Mavroudis D
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S42-5. PubMed ID: 11924243
    [No Abstract]   [Full Text] [Related]  

  • 16. New drugs for treating small cell lung cancer.
    Ettinger DS
    Lung Cancer; 1995 Jun; 12 Suppl 3():S53-61. PubMed ID: 7551957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lung cancer].
    Furuse K
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1917-24. PubMed ID: 9350236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment.
    Meert AP; Berghmans T; Branle F; Lemaître F; Mascaux C; Rubesova E; Vermylen P; Paesmans M; Sculier JP
    Anticancer Res; 1999; 19(5C):4379-90. PubMed ID: 10650780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Maintenance chemotherapy in advanced NSCLC].
    Krazkowski M
    Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S16-8. PubMed ID: 16719150
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors.
    Lissoni P; Brivio F; Fumagalli L; Messina G; Ghezzi V; Frontini L; Giani L; Vaghi M; Ardizzoia A; Gardani GS
    Int J Biol Markers; 2004; 19(2):135-40. PubMed ID: 15255546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.